About Zifi
Zifi is a company based in Aurangabad (India) founded in 2002 by Pushkar Soni and Keerthi Kiran Chennupati. The company has 6,548 employees as of April 08, 2024. Zifi operates in a competitive market with competitors including Insmed, Affinivax, Eligo Bioscience, Lodo Therapeutics and Symbiomix Therapeutics, among others.
- Headquarter Aurangabad, India
- Employees 6548 as on 08 Apr, 2024
- Founders Pushkar Soni, Keerthi Kiran Chennupati
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Fdc Ltd.
- Date of Incorporation 23 Sep, 1940
- Jurisdiction Chhatrapati Sambhaji Nagar, Maharashtra, India
-
Annual Revenue
$220.46 M (USD)14.31as on Mar 31, 2023
-
Net Profit
$23.31 M (USD)-10.33as on Mar 31, 2023
-
EBITDA
$30.18 M (USD)-1.07as on Mar 31, 2023
-
Latest Funding Round
- Investors
-
Employee Count
6548
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Zifi
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Seed - Zifi | Valuation |
investors |
Investors in Zifi
Zifi has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CreedCap Asia Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small & middle market focused boutique investment bank
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zifi
Financial Statements - Zifi
Zifi Comparisons
Competitors of Zifi
Zifi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insmed, Affinivax, Eligo Bioscience, Lodo Therapeutics and Symbiomix Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of small molecule inhibitors for rare lung diseases
|
|
| domain | founded_year | HQ Location |
Technology-based conjugate vaccines against infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
In vivo gene editing technology is developed for microbiome modulation.
|
|
| domain | founded_year | HQ Location |
Developer novel therapeutics to treat resistant infectious diseases and cancers using AI
|
|
| domain | founded_year | HQ Location |
Late-stage biopharma antibiotics for gynecological infections are developed.
|
|
| domain | founded_year | HQ Location |
Developer of vaccines for bacterial infections and cancer by using proprietary protein superglue technology
|
Latest news on Zifi
Frequently Asked Questions about Zifi
Zifi was founded in 2002 and raised its 1st funding round 13 years after it was founded.
Zifi is headquartered in Aurangabad, India. It is registered at Aurangabad, Maharashtra, India.
As of Apr 08, 2024, the latest employee count at Zifi is 6,548.
Annual revenue of Zifi is $220.46M as on Mar 31, 2023.
Zifi was founded in 2002 in Aurangabad, India, within the pharmaceuticals sector. Focus is placed on creating anti-infective therapies targeting bacterial diseases in both children and adults. Operations involve the production of products such as ZIFI 200, ZIFI-CV 200, ZIFI-LBX, ZIFI-O, and ZIFI TURBO. These address conditions including urinary tract infections, respiratory infections, ear infections, typhoid, and select sexually transmitted infections.
Zifi's top competitors include Insmed, MaaT Pharma and Basilea.
Zifi has 1 investor. Key investors include CreedCap Asia Advisors.